NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Operating Expenses

Annual Operating Expenses:

$1.74B+$285.70M(+19.67%)
December 31, 2024

Summary

  • As of today, NBIX annual total operating expenses is $1.74 billion, with the most recent change of +$285.70 million (+19.67%) on December 31, 2024.
  • During the last 3 years, NBIX annual operating expenses has risen by +$826.90 million (+90.73%).
  • NBIX annual operating expenses is now at all-time high.

Performance

NBIX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Quarterly Operating Expenses:

$541.60M+$11.00M(+2.07%)
September 30, 2025

Summary

  • As of today, NBIX quarterly total operating expenses is $541.60 million, with the most recent change of +$11.00 million (+2.07%) on September 30, 2025.
  • Over the past year, NBIX quarterly operating expenses has increased by +$117.90 million (+27.83%).
  • NBIX quarterly operating expenses is now at all-time high.

Performance

NBIX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

NBIX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+19.7%+27.8%
3Y3 Years+90.7%+86.8%
5Y5 Years+213.7%+201.9%

NBIX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+90.7%at high+86.8%
5Y5-Yearat high+213.7%at high+216.7%
All-TimeAll-Timeat high+9948.0%at high+2256.0%

NBIX Operating Expenses History

DateAnnualQuarterly
Sep 2025
-
$541.60M(+2.1%)
Jun 2025
-
$530.60M(-1.7%)
Mar 2025
-
$539.70M(+15.5%)
Dec 2024
$1.74B(+19.7%)
$467.20M(+10.3%)
Sep 2024
-
$423.70M(-0.7%)
Jun 2024
-
$426.70M(+7.4%)
Mar 2024
-
$397.20M(+13.0%)
Dec 2023
$1.45B(+19.4%)
$351.50M(+2.8%)
Sep 2023
-
$341.80M(-5.9%)
Jun 2023
-
$363.40M(-3.9%)
Mar 2023
-
$378.10M(+28.0%)
Dec 2022
$1.22B(+33.5%)
$295.30M(+1.8%)
Sep 2022
-
$290.00M(-7.9%)
Jun 2022
-
$314.80M(+5.1%)
Mar 2022
-
$299.60M(+24.4%)
Dec 2021
$911.40M(+28.7%)
$240.90M(-1.5%)
Sep 2021
-
$244.50M(+13.5%)
Jun 2021
-
$215.40M(+7.9%)
Mar 2021
-
$199.70M(+16.8%)
Dec 2020
$708.30M(+27.8%)
$171.00M(-4.7%)
Sep 2020
-
$179.40M(+2.3%)
Jun 2020
-
$175.30M(+0.7%)
Mar 2020
-
$174.00M(+12.6%)
Dec 2019
$554.10M(+36.9%)
$154.51M(+19.1%)
Sep 2019
-
$129.77M(-8.4%)
Jun 2019
-
$141.62M(+14.6%)
Mar 2019
-
$123.62M(+14.4%)
Dec 2018
$404.70M(+54.6%)
$108.09M(+12.7%)
Sep 2018
-
$95.88M(-1.6%)
Jun 2018
-
$97.46M(-9.4%)
Mar 2018
-
$107.58M(+31.3%)
Dec 2017
$261.73M(+61.2%)
$81.92M(+24.7%)
Sep 2017
-
$65.72M(+4.4%)
Jun 2017
-
$62.95M(-20.8%)
Mar 2017
-
$79.44M(+73.6%)
Dec 2016
$162.37M(+42.5%)
$45.76M(+20.3%)
Sep 2016
-
$38.03M(-8.4%)
Jun 2016
-
$41.50M(+99.0%)
Mar 2016
-
$20.86M(-31.6%)
Dec 2015
$113.97M(+76.9%)
$30.48M(-14.4%)
Sep 2015
-
$35.60M(+42.0%)
Jun 2015
-
$25.07M(+995.8%)
Mar 2015
-
$2.29M(-88.7%)
Dec 2014
$64.41M(+22.5%)
$20.24M(+21.7%)
Sep 2014
-
$16.64M(+17.6%)
Jun 2014
-
$14.15M(+12.8%)
Mar 2014
-
$12.55M(+3.7%)
Dec 2013
$52.60M(+1.8%)
$12.10M(+0.8%)
Sep 2013
-
$12.01M(-8.8%)
Jun 2013
-
$13.17M(+1.5%)
Mar 2013
-
$12.97M(+251.2%)
Dec 2012
$51.69M(+18.9%)
-$8.58M(-316.6%)
Sep 2012
-
$3.96M(+187.1%)
Jun 2012
-
$1.38M(-62.4%)
Mar 2012
-
$3.67M(+37.6%)
Dec 2011
$43.49M(-7.9%)
$2.67M(-76.1%)
Sep 2011
-
$11.14M(+1116.7%)
Jun 2011
-
-$1.10M(-110.7%)
Mar 2011
-
$10.23M(-7.7%)
DateAnnualQuarterly
Dec 2010
$47.22M(-12.7%)
$11.08M(-3.8%)
Sep 2010
-
$11.52M(+14.7%)
Jun 2010
-
$10.04M(-3.0%)
Mar 2010
-
$10.35M(+16.9%)
Dec 2009
$54.07M(-39.4%)
$8.85M(-7.8%)
Sep 2009
-
$9.61M(-34.9%)
Jun 2009
-
$14.75M(+4.8%)
Mar 2009
-
$14.07M(-6.0%)
Dec 2008
$89.22M(-58.2%)
$14.97M(+3.3%)
Sep 2008
-
$14.49M(-23.1%)
Jun 2008
-
$18.85M(-9.2%)
Mar 2008
-
$20.76M(-25.0%)
Dec 2007
$213.47M(+39.9%)
$27.69M(+2.0%)
Sep 2007
-
$27.16M(+8.1%)
Jun 2007
-
$25.13M(+1.3%)
Mar 2007
-
$24.82M(+52.6%)
Dec 2006
$152.55M(+2.4%)
$16.26M(-44.2%)
Sep 2006
-
$29.14M(-0.4%)
Jun 2006
-
$29.26M(+6.1%)
Mar 2006
-
$27.59M(+12.2%)
Dec 2005
$148.96M(+8.3%)
$24.59M(+197.9%)
Sep 2005
-
-$25.12M(-501.8%)
Jun 2005
-
$6.25M(-67.7%)
Mar 2005
-
$19.35M(-8.7%)
Dec 2004
$137.51M(-30.5%)
$21.18M(+598.9%)
Sep 2004
-
$3.03M(-77.4%)
Jun 2004
-
$13.39M(-9.1%)
Mar 2004
-
$14.73M(+171.8%)
Dec 2003
$197.87M(+62.6%)
$5.42M(-60.1%)
Sep 2003
-
$13.57M(+8.7%)
Jun 2003
-
$12.49M(-18.6%)
Mar 2003
-
$15.35M(+165.9%)
Dec 2002
$121.66M(+42.9%)
$5.77M(+77.5%)
Sep 2002
-
$3.25M(+3.2%)
Jun 2002
-
$3.15M(+15.4%)
Mar 2002
-
$2.73M(-23.1%)
Dec 2001
$85.12M(+62.5%)
$3.55M(+71.4%)
Sep 2001
-
$2.07M(-27.4%)
Jun 2001
-
$2.85M(+20.1%)
Mar 2001
-
$2.38M(-59.9%)
Dec 2000
$52.39M(+35.0%)
$5.93M(+136.3%)
Sep 2000
-
$2.51M(+14.7%)
Jun 2000
-
$2.19M(-2.0%)
Mar 2000
-
$2.23M(+18.2%)
Dec 1999
$38.80M(+28.9%)
$1.89M(+0.4%)
Sep 1999
-
$1.88M(-6.3%)
Jun 1999
-
$2.01M(+17.7%)
Mar 1999
-
$1.71M(-10.8%)
Dec 1998
$30.10M(+11.9%)
$1.91M(+5.4%)
Sep 1998
-
$1.81M(+35.5%)
Jun 1998
-
$1.34M(-12.4%)
Mar 1998
-
$1.53M(-80.7%)
Dec 1997
$26.90M(+55.5%)
$7.90M(+14.5%)
Sep 1997
-
$6.90M(+15.0%)
Jun 1997
-
$6.00M(+1.7%)
Mar 1997
-
$5.90M(-6.3%)
Dec 1996
$17.30M
$6.30M(+57.5%)
Sep 1996
-
$4.00M(-9.1%)
Jun 1996
-
$4.40M(+69.2%)
Mar 1996
-
$2.60M

FAQ

  • What is Neurocrine Biosciences, Inc. annual total operating expenses?
  • What is the all-time high annual operating expenses for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual operating expenses year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly total operating expenses?
  • What is the all-time high quarterly operating expenses for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly operating expenses year-on-year change?

What is Neurocrine Biosciences, Inc. annual total operating expenses?

The current annual operating expenses of NBIX is $1.74B

What is the all-time high annual operating expenses for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual total operating expenses is $1.74B

What is Neurocrine Biosciences, Inc. annual operating expenses year-on-year change?

Over the past year, NBIX annual total operating expenses has changed by +$285.70M (+19.67%)

What is Neurocrine Biosciences, Inc. quarterly total operating expenses?

The current quarterly operating expenses of NBIX is $541.60M

What is the all-time high quarterly operating expenses for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly total operating expenses is $541.60M

What is Neurocrine Biosciences, Inc. quarterly operating expenses year-on-year change?

Over the past year, NBIX quarterly total operating expenses has changed by +$117.90M (+27.83%)
On this page